Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A Phase I Study to Assess the Safety APL-2 as an Add-On to Standard of Care in Subjects with PNH

    ... within 12 months prior to screening Platelet count of > 30,000/mm3 Absolute neutrophil ...

    Clinical Trial last updated 07/19/2016 - 12:46pm.

  2. David Araten, MD

    ... clotting problems, and they tended to have much higher platelet counts than typically seen in patients with PNH. This led us to ... a blood clot . This number can be estimated from the platelet count and the percentage of PNH white cells. In the past there have ...

    Grant Recipient last updated 11/30/2016 - 10:51am.

  3. Pure Red Cell Aplasia (PRCA)

    ... cell count. The amounts of white blood cells and platelet remain normal. Transient or Acute Self-limited PRCA:   ...

    Topic section last updated 07/07/2016 - 3:14pm.

  4. Moderate, Severe, and Very Severe Aplastic Anemia: How are treatment decisions made?

    ... and may feel fine even though they have a low platelet count -- it can be more difficult to get them to understand there ... and may feel fine even though they have a low platelet count -- it can be more difficult to get them to understand there are ...

    Interview last updated 10/14/2015 - 12:47pm.

  5. EHA S826: Eltrombopag Added to Standard Immunosuppression as First Treatment in Severe Aplastic Anemia

    ... Eltrombopag (Promacta®) is a treatment that increases platelet counts and decreases bleeding risk. This phase 2 clinical ... at six months. Cohort 1 patients stopped needing platelet transfusions after a median 32 days of treatment. They stopped needing ...

    Research Review last updated 05/02/2016 - 9:10am.

  6. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... c.  At least one cytopenia (ANC < 1800/L or platelet count < 100,000/L or hemoglobin [Hgb] <10 g/dL) ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  7. Clinical Utility of Lenalidomide in the Treatment of Myelodysplastic Syndromes

    ... are near this del(5q) region include those that affect platelet production. Furthermore, the entity of 5q-syndrome (which is ... Phase III study is underway now. A study combining platelet growth factors and lenalidomide preliminarily demonstrated decreased ...

    Research Review last updated 05/02/2016 - 9:12am.

  8. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... to determine the time to neutrophil and platelet engraftment , to determine the time to immune ...

    Clinical Trial last updated 06/13/2016 - 2:06pm.

  9. New York Blood Center National Cord Blood Program

    ... is obtained to assess cord blood myeloid and platelet engraftment , transplant related mortality, overall ...

    Clinical Trial last updated 06/13/2016 - 1:43pm.

  10. MDS - Treatment (OLD)

    ... A transfusion for red blood cells takes 2 to 4 hours. A platelet transfusion takes 30 to 60 minutes. As with any medical ... donated stem cells engraft, you may need blood and/or platelet transfusions to keep your blood cells numbers up. During this time ...

    Topic section last updated 03/10/2016 - 11:01pm.